{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Understanding the Biologic Therapies of Probiotics, Prebiotics, and Synbiotics:Exploring Current Evidence for Use in Premature Infants for the Prevention of Necrotizing Enterocolitis

Activity Steps

Purpose of Activity

To provide nurses with an overview of current research and practice regarding efficacy and safety of probiotic, prebiotic, and synbiotic therapies with premature very low-birth-weight (VLBW) infants.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Describe the underdeveloped intestinal microbial environment and how biologic therapies physiologically alter it.
  2. Identify current evidence that has examined safety and efficacy of biologic therapies with the premature infant population.
Price: $24.95

Credits:

  • ANCC 2.5 CH
  • DC - BON 2.5 CH
  • KY-BON 2.5 CH

Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
--------------------------------------------------
This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia and Florida #50-1223. Your certificate is valid in all states.





Test Code: JPNN0715B
Published: Jul/Aug 2015
Expires: 12/31/2026
Required Passing Score: 13/18 (72%)
Authors: Mussie Asmerom, BSN, RN; Lindsay Crowe, BSN, RN; Terri Marin, PhD, NNP-BC